DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a report released on Friday. A number of other research firms also recently issued reports on DXCM. Morgan Stanley raised their price target on shares of DexCom from $75.00 to $82.00 and gave the stock […]
